{"id":"https://openalex.org/W1980940010","doi":"https://doi.org/10.1097/01.ju.0000096372.07687.86","title":"Endothelin Inhibition: Novel Therapy for Prostate Cancer","display_name":"Endothelin Inhibition: Novel Therapy for Prostate Cancer","alternate_titles":[],"publication_year":2003,"publication_date":"2003-11-18","ids":{"openalex":"https://openalex.org/W1980940010","doi":"https://doi.org/10.1097/01.ju.0000096372.07687.86","mag":"1980940010","pmid":"https://pubmed.ncbi.nlm.nih.gov/14610413"},"language":"en","primary_location":{"id":"doi:10.1097/01.ju.0000096372.07687.86","doi":"https://doi.org/10.1097/01.ju.0000096372.07687.86","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.ju.0000096372.07687.86","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1980940010"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111950819","display_name":"Joel B. Nelson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"JOEL B. NELSON","raw_affiliation_strings":["From the Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I170201317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111950819"],"corresponding_institution_ids":["https://openalex.org/I170201317"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":1.9773,"has_fulltext":false,"cited_by_count":67,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.85389352,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"170","issue":"6S","first_page":"S65","last_page":"S68"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.007300000172108412,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/endothelin-1","display_name":"endothelin-1","score":0.9549999833106995},{"id":"https://openalex.org/keywords/endothelin-receptors","display_name":"endothelin receptors","score":0.8140000104904175},{"id":"https://openalex.org/keywords/atrasentan","display_name":"atrasentan","score":0.9850000143051147},{"id":"https://openalex.org/keywords/androgen-refractory-prostate-cancer","display_name":"androgen-refractory prostate cancer","score":0.8600000143051147},{"id":"https://openalex.org/keywords/prostate-cancer-progression","display_name":"prostate cancer progression","score":0.9589999914169312},{"id":"https://openalex.org/keywords/vasoconstriction","display_name":"vasoconstriction","score":0.8140000104904175},{"id":"https://openalex.org/keywords/endothelin-axis","display_name":"endothelin axis","score":0.7110000252723694},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9183614253997803},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.8949992656707764},{"id":"https://openalex.org/C144980905","wikidata":"https://www.wikidata.org/wiki/Q24721308","display_name":"Endothelin receptor","level":3,"score":0.7098612785339355},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.6016662120819092},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5201526284217834},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4905051589012146},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4709680378437042},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4608267545700073},{"id":"https://openalex.org/C2781114028","wikidata":"https://www.wikidata.org/wiki/Q6746708","display_name":"Management of prostate cancer","level":4,"score":0.4160100817680359},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2564821243286133}],"mesh":[{"descriptor_ui":"D000077868","descriptor_name":"Atrasentan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017321","descriptor_name":"Clinical Trials, Phase I as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019332","descriptor_name":"Endothelin-1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D019332","descriptor_name":"Endothelin-1","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/01.ju.0000096372.07687.86","doi":"https://doi.org/10.1097/01.ju.0000096372.07687.86","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.ju.0000096372.07687.86","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"},{"id":"pmid:14610413","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14610413","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of urology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1548757985","https://openalex.org/W1571495789","https://openalex.org/W1958247899","https://openalex.org/W2025458001","https://openalex.org/W2025892095","https://openalex.org/W2031687428","https://openalex.org/W2045715263","https://openalex.org/W2065771840","https://openalex.org/W2084118479","https://openalex.org/W2098075349","https://openalex.org/W2136784153","https://openalex.org/W2140061644","https://openalex.org/W2143262962","https://openalex.org/W2145939385","https://openalex.org/W2162804111","https://openalex.org/W2408707960"],"related_works":["https://openalex.org/W1998976609","https://openalex.org/W2136368038","https://openalex.org/W2051378028","https://openalex.org/W2089984741","https://openalex.org/W2361546719","https://openalex.org/W4244588889","https://openalex.org/W1975213040","https://openalex.org/W17444167","https://openalex.org/W2007446210","https://openalex.org/W2044224342"],"abstract_inverted_index":{"PURPOSE:":[0],"Androgen":[1],"refractory":[2],"prostate":[3,17,26,49,80,102,147],"cancer":[4,18,27,103,148],"continues":[5],"to":[6,21,130],"evade":[7],"effective":[8],"treatment.":[9],"The":[10,140],"potent":[11,115],"vasoconstrictor":[12],"endothelin-1":[13],"is":[14,93,162],"produced":[15],"by":[16],"and":[19,29,37,41,55,59,86,105,128,137,155],"appears":[20],"have":[22,121,131],"a":[23],"role":[24,47,141],"in":[25,48,79,98,124,146,152],"progression":[28,104,136],"morbidity.":[30,106,138],"Background":[31],"on":[32,75,84,134],"the":[33,72,76,90,99,109,114,143,153],"endothelin":[34,38,77,91,110,144],"axis":[35,78,92,145],"(endothelin-1":[36],"receptors":[39],"ET(A)":[40,116],"ET(B)),":[42],"preclinical":[43,85],"studies":[44],"of":[45,52,71,101,142],"its":[46],"cancer,":[50],"results":[51],"phases":[53],"I":[54],"II":[56],"clinical":[57,87,126],"trials,":[58],"future":[60],"directions":[61],"are":[62],"reviewed.":[63],"MATERIALS":[64],"AND":[65],"METHODS:":[66],"A":[67],"review":[68],"was":[69],"conducted":[70],"published":[73],"data":[74],"cancer.":[81],"RESULTS:":[82],"Based":[83],"trial":[88],"data,":[89],"emerging":[94],"as":[95,113],"potentially":[96],"important":[97],"biology":[100],"Drugs":[107],"targeting":[108],"axis,":[111],"such":[112],"receptor":[117],"antagonist":[118],"atrasentan":[119],"(ABT-627),":[120],"been":[122],"studied":[123],"large":[125],"trials":[127],"appear":[129],"an":[132],"impact":[133],"disease":[135],"CONCLUSIONS:":[139],"deserves":[149],"further":[150],"investigation":[151],"laboratory":[154],"clinic.":[156],"This":[157],"new":[158],"strategy":[159],"for":[160],"intervention":[161],"promising.":[163]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1980940010","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
